Maze Therapeutics, Inc. - 10-Q Filing
Maze Therapeutics reports Q3 2026 results featuring Hercules Term Loan Facility obligations and various license agreement milestones.
Tickers: $MAZE
Maze Therapeutics reports Q3 2026 results featuring Hercules Term Loan Facility obligations and various license agreement milestones.
Tickers: $MAZE